Loading clinical trials...
Loading clinical trials...
This study is a prospective, randomized, double-blind, placebo-controlled evaluation of the safety of a topically applied formulation of rapamycin to cutaneous fibromatous lesions in subjects with Tub...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Texas Health Science Center, Houston
Collaborators
NCT00001975 · Tuberous Sclerosis
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT07403266 · Tuberous Sclerosis Complex (TSC)
NCT07369505 · Breast Cancer Metastatic, Renal Cell Carcinoma (RCC), and more
NCT06139172 · Telomeric 22Q13 Monosomy Syndrome, Tuberous Sclerosis, and more
The University of Texas Health Science Center
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions